DK1315700T3 - Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner - Google Patents

Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner

Info

Publication number
DK1315700T3
DK1315700T3 DK01978339T DK01978339T DK1315700T3 DK 1315700 T3 DK1315700 T3 DK 1315700T3 DK 01978339 T DK01978339 T DK 01978339T DK 01978339 T DK01978339 T DK 01978339T DK 1315700 T3 DK1315700 T3 DK 1315700T3
Authority
DK
Denmark
Prior art keywords
tetrahydropyridines
phenylcyclohexyl
phenyl
substituted
Prior art date
Application number
DK01978339T
Other languages
English (en)
Inventor
Boris Chizh
Claudia Hinze
Angelika Kerwer-Thomas
Gisela Henn
Michael Sattlegger
Bernd Sundermann
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1315700T3 publication Critical patent/DK1315700T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK01978339T 2000-09-08 2001-09-05 Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner DK1315700T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10044649A DE10044649A1 (de) 2000-09-08 2000-09-08 Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
PCT/EP2001/010224 WO2002020481A2 (de) 2000-09-08 2001-09-05 Substituierte 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine

Publications (1)

Publication Number Publication Date
DK1315700T3 true DK1315700T3 (da) 2007-02-19

Family

ID=7655648

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01978339T DK1315700T3 (da) 2000-09-08 2001-09-05 Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner

Country Status (17)

Country Link
US (1) US7034041B2 (da)
EP (1) EP1315700B1 (da)
JP (1) JP2004508353A (da)
AR (1) AR035489A1 (da)
AT (1) ATE344244T1 (da)
AU (2) AU1048602A (da)
CA (1) CA2421835A1 (da)
DE (2) DE10044649A1 (da)
DK (1) DK1315700T3 (da)
ES (1) ES2275740T3 (da)
HU (1) HUP0303676A2 (da)
MX (1) MXPA03001540A (da)
NZ (1) NZ525144A (da)
PE (1) PE20020369A1 (da)
PL (1) PL366065A1 (da)
PT (1) PT1315700E (da)
WO (1) WO2002020481A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10360793A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
NZ566062A (en) * 2005-09-28 2009-08-28 Auris Medical Ag Pharmaceutical compositions for the treatment of inner ear disorders comprising an arylcycloalkylamine such as ketamine and a biocompatible polymer
ES2862673T3 (es) 2011-12-12 2021-10-07 Zilentin AG Tratamiento del tinnitus mediante la modulación del cotransportador de cloruro NKCC1 en el sistema auditivo
JP6824502B2 (ja) 2015-10-15 2021-02-03 ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． オキサスピロ誘導体、その製造方法、及び医薬におけるその適用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1

Also Published As

Publication number Publication date
PL366065A1 (en) 2005-01-24
WO2002020481A3 (de) 2002-07-18
ES2275740T3 (es) 2007-06-16
EP1315700A2 (de) 2003-06-04
ATE344244T1 (de) 2006-11-15
PT1315700E (pt) 2007-01-31
WO2002020481A2 (de) 2002-03-14
US20030225116A1 (en) 2003-12-04
AR035489A1 (es) 2004-06-02
JP2004508353A (ja) 2004-03-18
HUP0303676A2 (hu) 2004-03-01
DE50111385D1 (de) 2006-12-14
AU2002210486B2 (en) 2006-06-01
AU1048602A (en) 2002-03-22
MXPA03001540A (es) 2003-06-06
PE20020369A1 (es) 2002-05-18
EP1315700B1 (de) 2006-11-02
NZ525144A (en) 2006-01-27
CA2421835A1 (en) 2003-03-07
DE10044649A1 (de) 2002-07-04
US7034041B2 (en) 2006-04-25

Similar Documents

Publication Publication Date Title
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
IS6561A (is) Bensóamíð píperidín efnasambönd sem P-efnis mótlyf
DE60115661D1 (de) 1,4-dihydropyridine als bradykininantagonisten
ATE354570T1 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
IS5941A (is) Píperidín sem CCR5 stillar
MXPA03003529A (es) Compuestos de piperidina como antialergicos.
NO20026125D0 (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
DE60139571D1 (de) Muscarin-antagonisten
NO20011436D0 (no) 2,2,6,6-dietyl-dimetyl-1-alkoksy-piperidin-forbindelser og deres korresponderende 1-oksider
ATE292128T1 (de) Piperidinderivate als neurokinin 1 antagonisten
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DK1315700T3 (da) Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner
BR9905634B1 (pt) piperidinas 4-substituìdas.
DK1119571T3 (da) Tricykliske Delta 3 piperidiner som alpha 2 antagonister.
NO20020597L (no) 1,4-substituerte 4,4-diaryl cykloheksaner
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
AU2002210486A1 (en) Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
DE50109598D1 (de) Spulenwechseleinrichtung
IT1317618B1 (it) Attrezzatura per l'inforcamento di pallets.
CH695521A5 (de) Strombegrenzendes Bauelement.
IT1320878B1 (it) Armadietto portautensili .
DE60139781D1 (de) 4-substituierte piperidinverbindung
SI1315700T1 (sl) Substituirani 4-fenil-1-(1-fenil-cikloheksil)-1,2,3,6-tetrahidropiridini
IL162619A0 (en) Piperidine-2,6-diones that are heterocyclically substituted in position 3